Abstract
In 39 hospitalized patients with suspected gastrointestinal bleeding and given intravenous51Cr-labeled red cells, reactions of three chemical spot tests for fecal occult blood were compared with the “true” blood loss as determined by stool radioassay. Guaiac reagent and orthotolidine (Hematest®) tablets were extremely sensitive, but yielded false-positive reaction rates of 72% and 76%, respectively on the 240 stool specimens compared. A modified guaiac test (Hemoccult®) exhibited a false-positive rate of 12%. Of the 27 patients entering the study due to positive guaiac or Hematest screening tests, 17 (63%) were not bleeding. Hemoccult, approximately 1/4 as sensitive as guaiac and Hematest, could miss lesions with low rates of bleeding unless multiple stools were tested. While barium had no effect, iron therapy or laxatives tended to lower both false-positive and false-negative reactions for all reagents. A positive Hemoccult test usually indicated significant gastrointestinal bleeding and would appear to be the test of choice provided at least 3 stools are tested to minimize false-negative results.
Similar content being viewed by others
References
Ostrow JD, Mulvaney CA, Hansell JR, Rhodes RS: Sensitivity and reproducibility of chemical tests for fecal occult blood with an emphasis on false-positive reactions. Am J Dig Dis 18:930–940, 1973
Irons GV, Kirsner JB: Routine chemical tests of the stool for occult blood: An evaluation. Am J Med Sci 249:247–260, 1965
Mollison PL, Veall N: The use of isotope51Cr as a label for red cells. Br J Hematol 1:62–74, 1955
Roche M, Perez-Gimenez ME, Layrisse M, DiPrisco E: Study of urinary and fecal excretion of radioactive chromium51 in man. Its use in the measurement of intestinal blood loss associated with hookworm infection. J Clin Invest 36:1183–1192, 1957
Ebaugh FG, Clemens T, Rodnan G, Peterson RE: Quantitative measurement of gastrointestinal blood loss. I. The use of radioactive Cr51 in patients with gastrointestinal hemorrhage. Am J Med 25:169–181, 1958
Cameron AD: Gastrointestinal blood loss measured by radio-active chromium. Gut 1:177–182, 1960
Jones NCH: Measurement of red-cell loss from the gastrointestinal tract using radioactive chromium. Br Med J 1:493–496, 1958
Hoerr SO, Bliss WR, Kauffman J: Clinical evaluation of various tests for occult blood in the feces. JAMA 141:1213–1217, 1949
Barnett RN: The guaiac test—correlation with clinical findings. Gastroenterology 21:540–543, 1952
Holt CL: The routine guaiac stool test. N Engl J Med 246:864–866, 1952
Cameron AB, Knoernschild HE, Zollinger RM: Detection of cancer and adenomas of the colon. The diagnostic value of fecal blood tests. Am J Surg 101:23–25, 1961
Kay AW: Management of obscure alimentary bleeding. Br Med J 1:1709–1713, 1962
Huntsman RG, Liddell J: Paper tests for occult blood in feces and some observation on the fate of swallowed red cells. J Clin Path 14:436–440, 1961
Ross G, Gray CH: Assessment of routine tests for occult blood in feces. Br Med J 1:1351–1354, 1964
Humphrey TJ, Goulston K: Chemical testing of occult blood in feces: “Hematest,” “Occultest,” and guaiac testing correlated with51chromium estimation of fecal blood loss. Med J Aust 1:1291–1293, 1969
Goldman P, Paver WKA, Corbett WH: The detection of occult blood in the feces. Med J Aust 1:755–758, 1964
Christensen F, Anker N, Mondrup M: Blood in feces. A comparison of the sensitivity and reproducibility of five chemical methods. Clin Chim Acta 57:23–27, 1974
Brayshaw JR, Harris F, McCurdy PR: The effect of oral iron therapy on the stool guaiac and orthotolidine reactions. Ann Int Med 59:172–179, 1963
Morgan TE, Roantree RJ: Evaluation of tests of occult blood in the feces. Significance of guaiac and orthotolidine tests after ingestion of iron. JAMA 164:1664–1667, 1957
Greegor DH: Occult blood testing for detection of asymptomatic colon cancer. Cancer 28:131–134, 1971
Steingold L, Roberts AA: Laboratory diagnosis of gastrointestinal bleeding. Gut 2:75–81, 1961
Owen CA, Cooper M, Grindlay JH, Bollman JL: Quantitative measurement of bleeding from alimentary tract by use of radio-chromium-labeled erythrocytes. Surg Forum 5:663–667, 1954
Hastings JB: Mass screening for colorectal cancer. Am J Surg 127:228–233, 1974
Author information
Authors and Affiliations
Additional information
Supported by a Medical Investigatorship (Dr. Ostrow) and Gastroenterology Training Grant (Dr. Morris) from the U.S. Veterans Administration.
Rights and permissions
About this article
Cite this article
Morris, D.W., Hansell, J.R., Ostrow, J.D. et al. Reliability of chemical tests for fecal occult blood in hospitalized patients. Digest Dis Sci 21, 845–852 (1976). https://doi.org/10.1007/BF01072075
Issue Date:
DOI: https://doi.org/10.1007/BF01072075